Policy Guidelines for Collaborative TB and HIV Services for Injecting and other Drug Users: An Integrated Approach

These new guidelines aim to reduce preventable deaths by, improving access to antiretroviral drugs and to isoniazid for drug users living with HIV. Isoniazid preventive therapy (IPT) significantly reduces the risk of TB disease in people living with HIV, but is not widely used. These are the first recommendations to actively include TB and HIV care within the context of support to drug users. They form part of the Evidence for Action series and build on policy guidance on both TB/HIV and injecting drug use.